MDB Capital Holdings Appoints Experienced Financial Expert Jeb Terry Sr. to Board and Audit Committee
Summary
MDB Capital Holdings, LLC appointed Jeb Terry Sr., a seasoned investor and financial expert, as an independent director and audit committee member, while Susanne Meline resigned due to retirement.
Key Events
-
Appointment of Independent Director
Jeb Terry Sr., a 73-year-old seasoned investor with over 20 years of experience in microcap medical and biotechnology, venture capital, and private equity, was appointed as an independent director, effective February 1, 2026.
-
Audit Committee Member & Financial Expert
Mr. Terry will serve as a member of the Board's audit committee and has been determined to be a 'financial expert' due to his extensive investment and business operational experience.
-
Director Compensation
Mr. Terry will receive an annual cash payment of $50,000 and an option award to acquire 100,000 Class A Shares, with vesting commencing on the first anniversary of the grant date.
-
Director Resignation
Susanne Meline resigned from the Board, effective February 1, 2026, citing general retirement after many years of service.
Analysis
The appointment of Mr. Jeb Terry Sr. as an independent director and audit committee member is a positive development for MDB Capital Holdings. His extensive experience in microcap medical and biotechnology companies, venture capital, and as a financial expert, brings valuable strategic and governance oversight, particularly as the company's stock trades near its 52-week low. The compensation package, including options for 100,000 shares, reflects the company's valuation of his expertise. The simultaneous resignation of Ms. Susanne Meline is noted as a routine retirement.
At the time of this filing, MDBH was trading at $3.20 on NASDAQ in the Finance sector, with a market capitalization of approximately $32.4M. The 52-week trading range was $3.11 to $7.98. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.